Handbook of Therapeutic Antibodies 2007
DOI: 10.1002/9783527619740.ch21
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Therapeutic Concepts I: ADEPT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…However, applications are often limited by their low cellular uptake and proteolytic stability. The expression of fusion proteins consisting of enzymes and cell targeting entities such as antibodies (Abs), translocation domains of toxins and cell penetrating peptides (CPPs) has enabled cellular delivery of the enzyme cargo 211214. Since the fusion takes place at the genetic level, it is not feasible to include chemically modified proteins or customize linkers equipped with various cleavage groups between the proteins in the design.…”
Section: Functional Supramolecular Protein Nanostructures (Pns) and Tmentioning
confidence: 99%
“…However, applications are often limited by their low cellular uptake and proteolytic stability. The expression of fusion proteins consisting of enzymes and cell targeting entities such as antibodies (Abs), translocation domains of toxins and cell penetrating peptides (CPPs) has enabled cellular delivery of the enzyme cargo 211214. Since the fusion takes place at the genetic level, it is not feasible to include chemically modified proteins or customize linkers equipped with various cleavage groups between the proteins in the design.…”
Section: Functional Supramolecular Protein Nanostructures (Pns) and Tmentioning
confidence: 99%